83 related articles for article (PubMed ID: 28901504)
1. Soluble interleukin‑2 receptor as a factor associated with angiogenesis in gastric cancer.
Yan WF; Nie CF; Wu G; Zhang JC; Zhu YZ; Zhang W; Sun PC
Mol Med Rep; 2017 Nov; 16(5):6916-6919. PubMed ID: 28901504
[TBL] [Abstract][Full Text] [Related]
2. Gastric cancer-associated enhancement of von Willebrand factor is regulated by vascular endothelial growth factor and related to disease severity.
Yang X; Sun HJ; Li ZR; Zhang H; Yang WJ; Ni B; Wu YZ
BMC Cancer; 2015 Feb; 15():80. PubMed ID: 25886574
[TBL] [Abstract][Full Text] [Related]
3. MACC-1 Promotes Endothelium-Dependent Angiogenesis in Gastric Cancer by Activating TWIST1/VEGF-A Signal Pathway.
Wang L; Zhou R; Zhao Y; Dong S; Zhang J; Luo Y; Huang N; Shi M; Bin J; Liao Y; Liao W
PLoS One; 2016; 11(6):e0157137. PubMed ID: 27280289
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor β1 (TGFβ1) and vascular endothelial growth factor (VEGF) in the blood of healthy people and patients with Graves' orbitopathy--a new mechanism of glucocorticoids action?
Kajdaniuk D; Marek B; Niedziołka-Zielonka D; Foltyn W; Nowak M; Siemińska L; Borgiel-Marek H; Głogowska-Szeląg J; Ostrowska Z; Drożdż L; Kos-Kudła B
Endokrynol Pol; 2014; 65(5):348-56. PubMed ID: 25301484
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma.
Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT
J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753
[TBL] [Abstract][Full Text] [Related]
7. Potential role of follicle-stimulating hormone (FSH) and transforming growth factor (TGFβ1) in the regulation of ovarian angiogenesis.
Kuo SW; Ke FC; Chang GD; Lee MT; Hwang JJ
J Cell Physiol; 2011 Jun; 226(6):1608-19. PubMed ID: 20945379
[TBL] [Abstract][Full Text] [Related]
8. Luteolin suppresses angiogenesis and vasculogenic mimicry formation through inhibiting Notch1-VEGF signaling in gastric cancer.
Zang M; Hu L; Zhang B; Zhu Z; Li J; Zhu Z; Yan M; Liu B
Biochem Biophys Res Commun; 2017 Aug; 490(3):913-919. PubMed ID: 28655612
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: prognostic and predictive markers in triple-negative and non-triple-negative breast cancer.
Bahhnassy A; Mohanad M; Shaarawy S; Ismail MF; El-Bastawisy A; Ashmawy AM; Zekri AR
Mol Med Rep; 2015 Jul; 12(1):851-64. PubMed ID: 25824321
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression.
Tang D; Gao J; Wang S; Ye N; Chong Y; Huang Y; Wang J; Li B; Yin W; Wang D
Tumour Biol; 2016 Feb; 37(2):1889-99. PubMed ID: 26323258
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of growth factors and growth factor receptors in gastric adenocarcinoma.
Kim JY; Jeon TJ; Bae BN; Kwon JE; Kim HJ; Park K; Shin E
APMIS; 2013 Feb; 121(2):95-104. PubMed ID: 23030255
[TBL] [Abstract][Full Text] [Related]
12. Decreased serum levels of the angiogenic factors VEGF and TGF-β1 in Alzheimer's disease and amnestic mild cognitive impairment.
Huang L; Jia J; Liu R
Neurosci Lett; 2013 Aug; 550():60-3. PubMed ID: 23827227
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
[TBL] [Abstract][Full Text] [Related]
14. Tumor angiogenesis of SCLC inhibited by decreased expression of FMOD via downregulating angiogenic factors of endothelial cells.
Ao Z; Yu S; Qian P; Gao W; Guo R; Dong X; Xu J; Zhang R; Jiang C; Ji F; Qian G
Biomed Pharmacother; 2017 Mar; 87():539-547. PubMed ID: 28081464
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid effects on angiogenesis are associated with mTOR pathway activity.
Ozmen A; Unek G; Kipmen-Korgun D; Mendilcioglu I; Sanhal C; Sakıncı M; Korgun ET
Biotech Histochem; 2016; 91(4):296-306. PubMed ID: 27007885
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF.
Hosseini H; Rajabibazl M; Ebrahimizadeh W; Dehbidi GR
Microvasc Res; 2015 Jan; 97():13-8. PubMed ID: 25250517
[TBL] [Abstract][Full Text] [Related]
17. Serum vascular endothelial growth factor/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer.
Chang YT; Chang MC; Wei SC; Tien YW; Hsu C; Liang PC; Tsao PN; Jan IS; Wong JM
Pancreas; 2008 Aug; 37(2):145-50. PubMed ID: 18665074
[TBL] [Abstract][Full Text] [Related]
18. Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients.
Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
Melanoma Res; 2006 Oct; 16(5):405-11. PubMed ID: 17013089
[TBL] [Abstract][Full Text] [Related]
19. Real Time Monitoring of Inhibition of Adipogenesis and Angiogenesis by (-)-Epigallocatechin-3-Gallate in 3T3-L1 Adipocytes and Human Umbilical Vein Endothelial Cells.
Tang W; Song H; Cai W; Shen X
Nutrients; 2015 Oct; 7(10):8871-86. PubMed ID: 26516907
[TBL] [Abstract][Full Text] [Related]
20. [Laboratory evaluation of TGFbeta1, IL-10, VEGF levels in vivo and in vitro in patients with solid tumors].
Danilova AB; Danilov AO; Fakhrutdinova OL; Baldueva IA; Moiseenko VM
Vopr Onkol; 2011; 57(6):759-66. PubMed ID: 22416394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
